Joseph Shulman, Chief Technical Officer at RHYTHM PHARMACEUTICALS, INC. (RYTM), sold 17,956 shares at $50.00 ($898K) on 2023-12-28, disclosed to the SEC on 2023-12-29.
Scheduled sale ($898k) by Chief Technical Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $50.01 | 5,015 | $251K | 27.9% |
| 2 | $50.01 | 5,015 | $251K | 27.9% |
| 3 | $50.00 | 7,926 | $396K | 44.1% |
| Total | $50.01 avg | 17,956 | $898K | 100% |
| Filing → |
| RYTM | SELL | 2025-10-30 | $648K | — | Filing → |
| RYTM | SELL | 2025-10-20 | $3.2M | — | Filing → |
| RYTM | SELL | 2025-09-04 | $3.5M | — | Filing → |